Urinary phenylacetylglutamine as dosing biomarker for patients with urea cycle disorders

M. Mokhtarani, G. A. Diaz, W. Rhead, U. Lichter-Konecki, J. Bartley, A. Feigenbaum, N. Longo, W. Berquist, S. A. Berry, R. Gallagher, D. Bartholomew, C. O. Harding, M. S. Korson, S. E. McCandless, W. Smith, J. Vockley, S. Bart, D. Kronn, R. Zori, S. CederbaumN. Dorrani, J. L. Merritt, Sandesh Sreenath-Nagamani, M. Summar, C. LeMons, K. Dickinson, D. F. Coakley, T. L. Moors, B. Lee, B. F. Scharschmidt

Research output: Contribution to journalArticlepeer-review

24 Scopus citations

Fingerprint Dive into the research topics of 'Urinary phenylacetylglutamine as dosing biomarker for patients with urea cycle disorders'. Together they form a unique fingerprint.

Chemical Compounds

Medicine & Life Sciences